DE60219965D1 - Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine - Google Patents

Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine

Info

Publication number
DE60219965D1
DE60219965D1 DE60219965T DE60219965T DE60219965D1 DE 60219965 D1 DE60219965 D1 DE 60219965D1 DE 60219965 T DE60219965 T DE 60219965T DE 60219965 T DE60219965 T DE 60219965T DE 60219965 D1 DE60219965 D1 DE 60219965D1
Authority
DE
Germany
Prior art keywords
zidovudine
water soluble
lamivudine
pharmaceutically acceptable
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60219965T
Other languages
English (en)
Other versions
DE60219965T2 (de
Inventor
Himadri Sen
Surya Kumar Jayanthi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lupin Ltd
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Publication of DE60219965D1 publication Critical patent/DE60219965D1/de
Application granted granted Critical
Publication of DE60219965T2 publication Critical patent/DE60219965T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE60219965T 2002-04-23 2002-04-23 Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine Expired - Fee Related DE60219965T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2002/000110 WO2003090762A1 (en) 2002-04-23 2002-04-23 Long acting compositions comprising zidovudine and lamivudine

Publications (2)

Publication Number Publication Date
DE60219965D1 true DE60219965D1 (de) 2007-06-14
DE60219965T2 DE60219965T2 (de) 2008-01-17

Family

ID=29266770

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60219965T Expired - Fee Related DE60219965T2 (de) 2002-04-23 2002-04-23 Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine

Country Status (12)

Country Link
US (1) US20050175694A1 (de)
EP (1) EP1501521B1 (de)
AT (1) ATE361080T1 (de)
AU (1) AU2002311622A1 (de)
BR (1) BR0215707A (de)
CZ (1) CZ20041117A3 (de)
DE (1) DE60219965T2 (de)
ES (1) ES2286258T3 (de)
HU (1) HUP0500217A2 (de)
MX (1) MXPA04010436A (de)
SK (1) SK285383B6 (de)
WO (1) WO2003090762A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5231242B2 (ja) * 2005-12-14 2013-07-10 シプラ・リミテッド ヌクレオチド及びヌクレオシド系逆転写酵素阻害剤（テノホビル及びラミブジン）を剤形の異なる部分に含む医薬組合せ
US20090258843A1 (en) * 2008-04-15 2009-10-15 Mallinckrodt Inc. Compositions Containing Antiviral Compounds and Methods of Using the Same
CN102488671A (zh) * 2011-12-15 2012-06-13 合肥华方医药科技有限公司 一种拉米夫定控释片制剂及其制备方法
CN113660928B (zh) * 2019-04-05 2024-04-05 盖迪亚生物技术公司 阴道片剂制剂
CN115813970B (zh) * 2022-11-25 2024-05-07 深圳福山生物科技有限公司 一种稳定释放的营养靶向组合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036228A (en) * 1975-09-11 1977-07-19 Alza Corporation Osmotic dispenser with gas generating means
EP0654038B1 (de) * 1992-08-04 1999-11-10 James M. Dunn Pharmazeutische formulierungen mit kontrollierter freigabe von 3'-azido-3'-deoxythymidin und verfahren zur verwendung
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
GB9809213D0 (en) * 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions
EA004443B1 (ru) * 1998-09-14 2004-04-29 Рэнбакси Лабораториз Лимитед Лекарственная форма для контролируемого высвобождения ципрофлоксацина для приема один раз в день

Also Published As

Publication number Publication date
ES2286258T3 (es) 2007-12-01
EP1501521B1 (de) 2007-05-02
SK285383B6 (sk) 2006-12-07
CZ20041117A3 (cs) 2005-04-13
AU2002311622A1 (en) 2003-11-10
US20050175694A1 (en) 2005-08-11
BR0215707A (pt) 2005-05-03
MXPA04010436A (es) 2005-05-27
ATE361080T1 (de) 2007-05-15
WO2003090762A1 (en) 2003-11-06
EP1501521A1 (de) 2005-02-02
DE60219965T2 (de) 2008-01-17
HUP0500217A2 (hu) 2005-06-28
SK50222004A3 (sk) 2005-05-05

Similar Documents

Publication Publication Date Title
KR100283709B1 (ko) 안정한 서방성 경구 투여 조성물
DK0923934T3 (da) Modified release-matrixformulering af cefaclor og cephalexin
EA200700049A1 (ru) Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
WO2004108162A3 (en) Controlled release pharmaceutical composition
IE970588A1 (en) Controlled release pharmaceutical compositions containing tiagabine
BR0009437A (pt) Amido pré-gelatinizado em uma formulação de liberação controlada
KR950007841A (ko) 트라마돌 염을 함유하는 서방성 약물 제제
WO2007048219A3 (en) Sustained drug release composition
MX2008000099A (es) Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones.
BR0312347A (pt) Composição farmacêutica oral, usos da espessura de revestimento de um material de revestimento dependente do ph de dissolução, de um material de revestimento, e de um material de polimetacrilato
RU2333745C2 (ru) Композиции с контролируемым высвобождением
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
BG105339A (en) Orally administered controlled drug delivery system providing temporal and spatial control
RS50937B (sr) Farmaceutska kompozicija koja sadrži metformin i glibenklamid za lečenje šećerne bolesti tipa ii
IL174830A0 (en) Pellets containing venlafaxine hydrochloride, pharmaceutical compositions comprising them and processes for their preparation
CA2352211A1 (en) Sustained release matrix systems for highly soluble drugs
ATE549015T1 (de) Pharmazeutische wirkstoffhaltige formulierung mit überzug
SK282506B6 (sk) Tableta obsahujúca paracetamol a domperidon
DE60219965D1 (de) Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine
WO2004078111A3 (en) Extended release minocycline compositions and processes for their preparation
UA89349C2 (uk) Таблетка без покриття, яка містить оланзапін, та спосіб її одержання
SG145717A1 (en) Composition for releasing a weak base for an extended period of time
PT1461017E (pt) Composicao farmaceutica para a libertacao controlada de um antibiotico beta-lactamico
NO20073850L (no) Farmasoytisk polymersammensetning for oral kontrollert frigivelsesavlevering av terbutalinsulfat
MXPA06007511A (es) Revestimientos de granulos de farmaco que imparten resistencia a la embarradura durante la compresion mecanica.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee